| Liberty Ann Helgeson, RN | |
|
3200 Providence Dr, Anchorage, AK 99508-4615 | |
| (907) 350-6717 | |
| Not Available |
| Full Name | Liberty Ann Helgeson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Emergency |
| Location | 3200 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013521145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WE0003X | Registered Nurse - Emergency | NURR24259 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Liberty Ann Helgeson, RN 1912 Talkeetna St, Anchorage, AK 99508-3249 Ph: (907) 350-6717 | Liberty Ann Helgeson, RN 3200 Providence Dr, Anchorage, AK 99508-4615 Ph: (907) 350-6717 |
News Archive
By seeing what substances and molecules affect the development of our diseases, we can develop drugs that prevent or cure diseases. In her dissertation at Kalmar University in Sweden, Ann Novotny has found that the signal molecule acetylcholine (ACh) is important for the progress of cancer of the large intestine and colon, knowledge that is important to factor in when developing drugs that block the effects of Ach on tumor cells.
Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and FormuTech Nutrition, one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire FormuTech.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
Caris Life Sciences and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry™ at the 50th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., this weekend.
› Verified 6 days ago
Sandy Marie Stagelman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3101 Penland Pkwy, Suite J11, Anchorage, AK 99508 Phone: 907-334-8535 Fax: 907-279-8032 | |
Mrs. Gloria Denise Winchester-dunbar, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2530 Debarr Rd, Anchorage, AK 99508 Phone: 907-258-7575 | |
Amanda Piraino, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1240 Elegante Ln, Anchorage, AK 99501 Phone: 907-782-5828 | |
Kale Recaido, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 744 E 13th Ave, Anchorage, AK 99501 Phone: 808-557-7367 | |
Trent S Roberts, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Kristine Clifton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1650 Bragaw St, Anchorage, AK 99508 Phone: 907-433-7350 | |
Jessica Leigh Akin, Registered Nurse Medicare: Medicare Enrolled Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-6351 |